Anzeige
Mehr »
Login
Sonntag, 20.06.2021 Börsentäglich über 12.000 News von 662 internationalen Medien
Diese POWER-AKTIE trotzt allem und steigt einfach weiter! Ausbruch unter hohem Volumen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QJR8 ISIN: US42237K4094 Ticker-Symbol: 1HB 
Tradegate
18.06.21
17:30 Uhr
6,000 Euro
+0,100
+1,69 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
HEAT BIOLOGICS INC Chart 1 Jahr
5-Tage-Chart
HEAT BIOLOGICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
5,9606,10018:36
5,9606,12018.06.

Aktuelle News zur HEAT BIOLOGICS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
11.06.VXRT, NOVN, HTBX and CRIS among midday movers47
10.06.Heat Biologics Surges On Patent Filing97
HEAT BIOLOGICS Aktie jetzt für 0€ handeln
10.06.Heat Biologics records biggest one-day gain in over four months72
04.06.HEAT BIOLOGICS, INC. - 8-K, Current Report36
04.06.Heat Biologics to Showcase Favorable Survival Data of HS-110 in Previously Treated Non-Small Cell Lung Cancer Patients at 2021 American Society of Clinical ...33
20.05.HEAT BIOLOGICS, INC. - 8-K, Current Report19
20.05.Heat Biologics Announces Promising Survival Data of HS-110 in Two Treatment Settings of Lung Cancer; Selected for Presentation at 2021 American Society ...38
19.05.Heat Biologics Announces Multiple Presentations on PTX-35 at the Upcoming 3rd Annual Treg Directed Therapies Summit20
14.05.HEAT BIOLOGICS, INC. - 10-Q/A, Quaterly Report15
10.05.Heat Biologics Appoints Anthony Manning, Ph.D. as Chief Scientific Advisor21
05.05.HEAT BIOLOGICS, INC. - 8-K, Current Report10
05.05.HEAT BIOLOGICS, INC. - 10-Q, Quaterly Report12
05.05.Heat Biologics Provides First Quarter 2021 Business Update; Reports Continued Progress on Oncology and COVID-19 Vaccine Programs19
12.04.HEAT BIOLOGICS, INC. - 8-K, Current Report63
12.04.Heat Biologics, Inc.: Heat Biologics Announces New Preclinical Data on PTX-35, Demonstrating Decreased Regulatory T-cell (Treg) Activity and Delayed Tumor Progression at American Association for Cancer Research (AACR) Annual Meeting 2021349DURHAM, NC / ACCESSWIRE / April 12, 2021 / Heat Biologics, Inc. (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system...
► Artikel lesen
25.03.HEAT BIOLOGICS, INC. - 10-K, Annual Report23
25.03.HEAT BIOLOGICS, INC. - 8-K, Current Report24
25.03.Heat Biologics, Inc.: Heat Biologics Provides Year-End Business Update530DURHAM, NC / ACCESSWIRE / March 25, 2021 / Heat Biologics, Inc. (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system...
► Artikel lesen
12.03.HEAT BIOLOGICS, INC. - 8-A12B/A, Registration of securities44
12.03.HEAT BIOLOGICS, INC. - 8-K, Current Report20
Seite:  Weiter >>
64 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
25,10,20